GlassScriptPhysician profile
Rola Ajami
NPI 1487254850
$2,363.67
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $927 · 2022: $1,025 · 2023: $292 · 2024: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $411.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $381.43 | 2021-2023 | Relistor |
| Scilex Pharmaceuticals INC. | $315.21 | 2021-2023 | Ztlido |
| Abbvie INC. | $287.38 | 2021-2023 | Botox |
| Amgen INC. | $219.48 | 2021-2022 | |
| Medtronic, INC. | $161.28 | 2022-2023 | Intellis Adaptivestim |
| Collegium Pharmaceutical, INC. | $123.23 | 2021-2023 | Belbuca |
| Davol INC. | $120.41 | 2024 | Arista Ah Flexitip |
| Grt US Holding, INC. | $92.08 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $86.00 | 2022 | |
| Uswm, LLC | $76.21 | 2021 | |
| Virtus Pharmaceuticals LLC | $70.41 | 2021 | |
| Boston Scientific Corporation | $57.95 | 2021-2023 | Wavewriter Alpha Prime 16 |
| Fidia Pharma USA INC. | $43.48 | 2022 | |
| Redhill Biopharma INC. | $43.46 | 2021-2022 | |
| Pfizer INC. | $36.44 | 2023 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $35.97 | 2021 | |
| Averitas Pharma INC. | $33.51 | 2023 | Qutenza |
| Radius Health, INC. | $33.39 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $27.97 | 2021 | |
| Biodelivery Sciences International, INC. | $26.54 | 2021 | |
| Almatica Pharma LLC | $24.21 | 2021 | |
| Stimwave Technologies Incorporated | $22.51 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $16.96 | 2022 | |
| Relievant Medsystems, INC. | $14.82 | 2023 | Intracept |
| Indivior INC. | $13.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rola Ajami listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.